Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis. 1995

T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.

This study assessed glomerular endothelin (ET)-1, ET-3, and ET-receptor A and B mRNA levels in puromycin aminonucleoside (PAN)-induced nephrosis. During the nephrotic stage, 8 days after PAN injection, ET-1 and ETB receptor mRNA were elevated by 2.8 +/- 0.8-fold (P < 0.01) and 2.4 +/- 0.9-fold (P < 0.01), respectively, as compared with controls. These mRNA levels decreased to control levels by Day 20, when the nephrosis was in remission. In contrast, glomerular ETA receptor mRNA levels did not change in PAN nephrosis or control rats during the experimental period. ET-3 mRNA was not detected in the glomeruli of PAN nephrosis or control rats. Additionally, plasma ET concentration and glomerular ET production were measured in PAN nephrosis and control rats by radio-immunoassay. Eight days after PAN injection, ET-1 levels in plasma and glomeruli were not significantly altered in rats with PAN-induced nephrosis (glomeruli, 104.68 +/- 16.46 pg/mg of protein versus 98.24 +/- 13.68 pg/mg of protein; plasma, 2.68 +/- 1.10 versus 2.52 +/- 0.98 pg/mL). The administration of methylprednisolone to PAN rats resulted in the rapid disappearance of proteinuria and partially attenuated the increased ET-1 and ETB receptor gene expression in the glomeruli. These data indicate that glomerular ET-1 and ETB receptor expression in PAN nephrosis in increased at the mRNA level and that methylprednisolone treatment results in an attenuated increase.

UI MeSH Term Description Entries
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D009401 Nephrosis Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA. Nephroses
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D011692 Puromycin Aminonucleoside PUROMYCIN derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties and can cause nephrosis. 3'-Amino-3'-deoxy-N,N-dimethyladenosine,Aminonucleoside,3' Amino 3' deoxy N,N dimethyladenosine,Aminonucleoside, Puromycin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived

Related Publications

T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
January 1980, Renal physiology,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
December 1970, Laboratory investigation; a journal of technical methods and pathology,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
June 1987, Kidney international,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
May 2018, Pediatric research,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
October 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
April 1986, Nihon Jinzo Gakkai shi,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
September 1987, The American journal of pathology,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
May 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
September 1989, Acta pathologica japonica,
T Nakamura, and I Ebihara, and M Fukui, and S Osada, and Y Tomino, and T Masaki, and K Goto, and Y Furuichi, and H Koide
February 1985, Kidney international,
Copied contents to your clipboard!